MARY ANN GRAY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARY ANN GRAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARY ANN GRAY. MARY ANN GRAY is a Director in JUNIPER PHARMACEUTICALS INC ($JNP) and a Director in Sarepta Therapeutics, Inc. ($SRPT) and a in DYAX CORP ($DYAX) and a Director in DYAX CORP ($DYAX) and a Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and a in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in SENOMYX INC ($SNMX) and a Director in Seneca Biopharma, Inc. ($SNCA) and a Director in Galena Biopharma, Inc. ($GALE) and a Director in Keros Therapeutics, Inc. ($KROS) and a in RAPT Therapeutics, Inc. ($RAPT) and a Director in RAPT Therapeutics, Inc. ($RAPT).
Address: 3165 PORTER DRIVE PALO ALTO 94304 CA
Companies in which MARY ANN GRAY is an Insider
ACADIA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY:
Holdings: 149,476 shares
Current Value: $5,708,488
Latest Transaction: Jun 09 2016
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DYAX CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of MARY ANN GRAY:
Holdings: 0 shares
Latest Transaction: Jan 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
JUNIPER PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 15 2018
$JNP Market Capitalization: $53.67M
$JNP Previous Close: $4.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Keros Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY: Director
Holdings: 0 shares
Latest Transaction: Dec 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MABVAX THERAPEUTICS HOLDINGS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY: Director
Holdings: 5,000 shares
Current Value: $14,850
Latest Transaction: May 31 2005
$MBVX Market Capitalization: $18.01M
$MBVX Previous Close: $2.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PALISADE BIO, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MARY ANN GRAY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 26 2021
$SNCA Market Capitalization: $28.01M
$SNCA Previous Close: $3.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RAPT Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY:
Holdings: 0 shares
Latest Transaction: Jun 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sarepta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY: Director
Holdings: 8,436 shares
Current Value: $246,078
Latest Transaction: Mar 05 2021
$SRPT Market Capitalization: $1.60B
$SRPT Previous Close: $29.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SELLAS Life Sciences Group, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARY ANN GRAY: Director
Holdings: 39,167 shares
Current Value: $54,834
Latest Transaction: Oct 10 2017
$SLS Market Capitalization: $9.04M
$SLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SENOMYX INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of MARY ANN GRAY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 02 2018
$SNMX Market Capitalization: $54.90M
$SNMX Previous Close: $1.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARY ANN GRAY
Sentiment: All, ACAD, DYAX, JNP, KROS, MBVX, SNCA, RAPT, SRPT, SLS, SNMX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2021 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Option Exercise | A | 19.30 | 7,500 | 144,750 | 7,500 | ||
| Apr 26 2021 | SNCA | Seneca Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Apr 02 2021 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Option Exercise | A | 22.20 | 3,822 | 84,848 | 3,822 | ||
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 2,726 | 0 | 8,436 | 5.7 K to 8.4 K (+47.74 %) |
| Dec 21 2020 | KROS | Keros Therapeutics ... | GRAY MARY ANN | Director | Option Exercise | A | 82.74 | 16,587 | 1,372,408 | 16,587 | |
| Dec 10 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | M | 0.00 | 967 | 0 | 967 |